Zevra Therapeutics reports positive pediatric data
Zevra Therapeutics (NASDAQ:ZVRA) reported positive data for MIPLYFFA (arimoclomol) from a phase 2/3 open-label pediatric substudy in infants with Niemann-Pick disease type C.
Todas as matérias desta seção, das mais recentes às mais antigas — página 144 de 371.
Zevra Therapeutics (NASDAQ:ZVRA) reported positive data for MIPLYFFA (arimoclomol) from a phase 2/3 open-label pediatric substudy in infants with Niemann-Pick disease type C.
Shopify (NYSE:SHOP) plans to ban all vape product sales from its e-commerce platform as early as this week, following pressure from U.S. state attorneys general.
Oracle (NYSE:ORCL) cut about 21,000 full-time jobs over the past year while accelerating its investment in AI data center infrastructure.
Meta (NASDAQ:META) launched a new line of AI-powered smart glasses called Meta Glasses, priced from $299 and designed in-house while still working in partnership with EssilorLuxottica.
Trinity Biotech (NASDAQ:TRIB) launched Trinovium, a subsidiary dedicated to advanced liquid cooling fluids and intelligence systems for AI and high-performance computing data centers.
Micron Technology (NASDAQ:MU) announced a strategic agreement with Anthropic that includes a memory and storage supply deal, technical collaboration on AI infrastructure, and a strategic investment in Anthropic’s Series H funding round.
Revolution Medicines (NASDAQ:RVMD) began dosing patients in its global Phase 3 RASolute 305 trial for metastatic pancreatic cancer.
Allergan Aesthetics (NYSE:ABBV) received Health Canada approval for Boey (trenibotulinumtoxinE) to temporarily improve the appearance of moderate to severe glabellar (frown) lines in adults.
Fortitude Mining Holdings and HeartSciences (NASDAQ:HSCS) have entered into a definitive merger agreement to combine in an all-stock transaction expected to close in the second half of 2026.
Gilead Sciences (NASDAQ:GILD) announced that the European Commission has granted marketing authorization for Trodelvy (sacituzumab govitecan-hziy) as monotherapy for adult patients with unresectable or metastatic triple-negative breast cancer who have not received prior systemic therapy and are not candidates for PD-1 or PD-L1 inhibitor treatment.
Sunstone Hotel Investors (NYSE:SHO) agreed to sell the Hyatt Regency San Francisco to Blackstone Real Estate for $279 million.
Bristow Group (NYSE:VTOL) executed an agreement to acquire Berry Aviation from Acorn Capital Management for $105 million.
Veeva Systems (NYSE:VEEV) acquired Copli, a pioneer in agentic medical, legal, and regulatory solutions, and launched Veeva Falcon MLR.
Sunbelt Rentals Holdings (NYSE:SUNB) reported fiscal fourth quarter and full-year 2026 results with record full-year total revenue of $11.154 billion.
AerCap (NYSE:AER) delivered the first new GE-powered Boeing 787-9 aircraft to Thai Airways on June 23, 2026 at Boeing’s Delivery Center in Everett, Seattle.
Korn Ferry (NYSE:KFY) reported fourth quarter FY'26 fee revenue of $759.8 million, a 7% increase from the prior year.
Applied Industrial Technologies (NYSE:AIT) announced a quarterly cash dividend of $0.51 per common share to reward its equity investors.
Teleflex Incorporated (NYSE:TFX) announced the beginning of enrollment in the BIOMAG-III Study, a global pivotal trial evaluating the Freesolve Resorbable Magnesium Scaffold (RMS).
Jiayin Group (NASDAQ:JFIN) reported first quarter 2026 unaudited results with transaction volume of RMB19.3 billion, a 45.8% decrease from the prior year.
Dorian LPG (NYSE:LPG) entered into an agreement with HD Hyundai to construct one 90,000 cbm very large gas carrier for delivery in July 2029 at a price of approximately $115 million.
AEVEX (NYSE:AVEX) has been awarded the next option year of the Fire Integrated Real-Time Intelligence System (FIRIS) contract by the California Governor’s Office of Emergency Services (Cal OES), valued at $15.2 million.
Organon (NYSE:OGN) and Shanghai Henlius Biotech, made BILDYOS (denosumab injection) 60 mg/1 mL and TUZEMTY (denosumab injection) 120 mg/1.7 mL available in Canada.
AbbVie (NYSE:ABBV) said the European Commission has granted approval for its oral antiviral MAVIRET (glecaprevir/pibrentasvir) to treat acute hepatitis C virus (HCV) infection in adults and pediatric patients aged 3 years and older with compensated liver disease, with or without cirrhosis.
Brent crude futures fell $1.09, or 1.4%, to $76.81 a barrel, while U.S. West Texas Intermediate crude declined 87 cents, or 1.2%, to $72.99 a barrel as of 0607 GMT.
Tem um segundo para um cookie? 🍪Os cookies essenciais mantêm a Grafa funcionando bem. Alguns opcionais nos ajudam a ver o que está funcionando para melhorarmos. Você tem o controle — pode mudar de ideia quando quiser. Política de cookies · Política de privacidade